Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Klatskin Tumor 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Hormones × Gastrointestinal × Clear all
NCT05128890 2026-03-20

Evaluation of Resection Techniques for Pancreatic Tumors

Methodist Health System

Recruiting
431 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06850753 2025-08-21

SURE-LT

Oslo University Hospital

Phase NA Recruiting
15 enrolled
Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡